Answer
Women of childbearing potential must use highly effective contraception during eribulin mesylate treatment and for 7 months afterward, while men with partners of childbearing potential must use effective contraception during treatment and for 4 months afterward.
Sources for this answer
- Eribulin Eisai 0.44 mg/ml solution for injectionEisai Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked